drugset
drugset / Trial / NCT03808844

A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects

NCT03808844 ↗

Phase 3 Completed 178 enrolled Sichuan Haisco Pharmaceutical Group Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multi-center, randomized, double-blind, propofol-controlled phase III clinical trial. The primary objective is to compare the efficacy and safety between propofol and HSK3486 for the induction of general anesthesia in elective surgery subjects, so as to provide reference for marketing registration of HSK3486.

Timeline

Start
2019-03-22
Primary completion
2019-08-14
Completion
2019-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.4 mg/kg —
Comparator Propofol Small molecule 2 mg/kg —

Indications

No indication recorded.